evolut
cat
solitari
speci
pressur
felin
virus
develop
highli
effici
transmiss
strategi
abil
persist
within
host
long
period
time
aptitud
adapt
natur
vaccineinduc
immunolog
pressur
characterist
render
felin
virus
particularli
danger
catteri
shelter
rescu
home
cat
differ
background
live
close
proxim
possibl
induc
shortterm
resist
newcom
cat
broad
varieti
virus
could
help
prevent
dissemin
virus
within
outsid
facil
oligonucleotid
odn
contain
unmethyl
cytosin
phosphat
guanosin
cpg
motif
stimul
innat
immun
respons
mammal
previous
shown
odn
class
cpg
odn
promot
express
felin
immun
cell
potent
antivir
molecul
increas
resist
felin
fibroblast
epitheli
cell
line
five
common
felin
virus
aim
test
safeti
extent
biolog
effect
odn
domest
cat
perform
initi
vivo
experi
two
cat
inject
molecul
subcutan
two
addit
cat
receiv
control
treatment
side
effect
administr
odn
observ
moreov
molecul
induc
express
myxoviru
resist
mx
gene
marker
instig
innat
antivir
process
blood
well
oral
conjunctiv
rectal
mucosa
cell
indic
system
biolog
activ
molecul
protect
potenti
viral
entri
site
mx
mrna
level
alreadi
elev
blood
h
post
inject
odn
reach
peak
level
within
h
return
basal
valu
h
administr
molecul
similar
induct
pattern
observ
analyz
mucos
cell
plasma
collect
treat
cat
regular
interv
h
could
moreov
induc
mx
mrna
express
cell
increas
resist
cell
felin
caliciviru
inocul
final
mx
mrna
level
measur
blood
correl
degre
viral
inhibit
induc
plasma
cat
experiment
time
point
result
altogeth
underlin
promis
potenti
odn
promot
antivir
defens
mechan
induc
temporari
resist
viral
infect
vivo
domest
cat
felin
virus
evolutionarili
acquir
elabor
strategi
persist
within
host
popul
although
domest
cat
social
speci
ancestor
african
wildcat
feli
silvestri
lybica
led
solitari
way
life
driscol
et
al
result
felin
virus
possess
effici
transmiss
strategi
enabl
infect
suscept
individu
upon
rare
contact
anim
pontier
et
al
addit
pathogen
appli
hit
stay
strategi
induc
asymptomat
latent
andor
persist
infect
remain
long
time
within
host
infect
hilleman
felin
virus
conserv
opportunist
behavior
cours
time
modern
anim
welfar
give
free
way
pathogen
readili
spread
everi
individu
live
group
biolog
properti
felin
virus
today
particularli
problemat
catteri
shelter
infecti
pressur
significantli
increas
high
social
contact
rate
among
stress
individu
differ
medic
background
help
et
al
pedersen
et
al
prado
et
al
healthi
carrier
anim
threaten
infect
suscept
resid
particip
viral
dissemin
acut
infect
cat
leav
facil
infect
may
discov
month
year
later
connect
stay
catteri
shelter
often
overseen
sadli
felin
virus
fatal
diseas
manag
gener
long
tediou
lutz
et
al
radford
et
al
thiri
et
al
truyen
et
al
specif
therapi
moreov
unavail
felin
viral
diseas
exist
tend
costli
emphasi
therefor
set
effect
prophylaxi
effici
protect
vaccin
howev
requir
lengthi
protocol
quarantin
naiv
anim
remain
logist
difficult
overcrowd
shelter
furthermor
select
pressur
alter
field
strain
varieti
felin
virus
efficaci
avail
vaccin
question
hurley
et
al
radford
et
al
possibl
transient
increas
resist
broad
spectrum
virus
cat
place
catteri
shelter
could
restrict
viral
spread
within
facil
significantli
contribut
well
cat
owner
like
refer
idea
teflon
domest
cat
analog
ronald
reagan
teflon
presid
thoma
et
al
strong
critic
administr
seem
effect
reagan
popular
felin
virus
could
affect
teflon
cat
oligonucleotid
contain
unmethyl
cytosineguanosin
pair
cpg
odn
known
stimul
innat
branch
immun
system
mice
primat
mani
domest
speci
abel
et
al
kamstrup
et
al
kurata
et
al
mena
et
al
rankin
et
al
made
way
human
clinic
trial
gupta
agraw
klinman
et
al
murad
clay
vollmer
krieg
accord
sequenc
backbon
structur
immunolog
effect
sever
class
cpg
odn
defin
among
class
b
wide
studi
vollmer
et
al
class
cpg
odn
cpga
compris
sever
cpg
motif
endonucleasesensit
phosphodiest
backbon
flank
synthet
phosphorothio
poli
g
stretch
cpg
motif
cpgb
molecul
fulli
embed
endonucleaseresist
phosphorothio
backbon
structur
differ
known
affect
stabil
cpg
odn
class
vivo
also
cellular
target
well
ensu
immun
respons
although
class
trigger
tolllik
receptor
tlr
cpga
effici
induc
product
type
interferon
ifn
plasmacytoid
dendrit
cell
pdc
cpgb
known
stimul
monocyt
b
cell
date
studi
report
effect
cpg
odn
cat
indic
molecul
possess
potenti
mount
advantag
immun
respons
context
viral
infect
way
felin
immun
cell
display
increas
prolifer
stimul
class
roberttissot
et
al
class
b
wernett
et
al
cpg
odn
furthermor
addit
class
b
cpg
odn
allergen
adjuv
felin
asthma
model
promot
induct
helper
th
respons
involv
immun
cell
capabl
interfer
viral
propag
reinero
et
al
sever
class
cpg
odn
also
shown
promot
express
typic
cytokin
satoh
et
al
extens
studi
recent
report
odn
prototyp
cpga
could
induc
robust
antivir
immun
respons
domest
cat
vitro
roberttissot
et
al
felin
peripher
blood
mononuclear
cell
pbmc
stimul
molecul
display
stronger
prolifer
capac
higher
presenc
surfac
costimulatori
molecul
enhanc
express
potent
antivir
cytokin
includ
variou
subtyp
felin
ifn
belong
type
ifn
famili
solubl
molecul
pbmc
supernat
enhanc
resist
target
felin
cell
line
inocul
five
common
felin
virus
includ
felin
caliciviru
fcv
herpesviru
fhv
coronaviru
fcov
parvoviru
fpv
leukaemia
viru
felv
moreov
found
higher
express
level
myxoviru
resist
mx
gtpase
gene
directli
sole
induc
type
ifn
haller
koch
strongli
correl
decreas
suscept
target
cell
replic
virus
order
investig
adequaci
odn
candid
prophylact
induct
broadspectrum
antivir
protect
domest
cat
conduct
initi
vivo
experi
present
studi
assess
safeti
odn
clinic
usag
measur
extent
kinet
biolog
effect
singl
inject
final
evalu
vivo
antivir
potenti
molecul
four
male
castrat
specif
pathogen
free
spf
cat
purchas
liberti
research
inc
waverli
ny
usa
includ
studi
spf
statu
anim
verifi
previous
describ
museux
et
al
time
experi
cat
month
old
kept
animalfriendli
environ
optim
etholog
condit
facil
vetsuiss
faculti
univers
zurich
geret
et
al
present
studi
offici
approv
veterinari
offic
swiss
canton
zurich
permit
tvb
two
cat
treat
odn
alexi
biochem
enzo
life
scienc
ag
switzerland
one
cat
treat
control
odn
alexi
biochem
last
cat
treat
endotoxinfre
water
odnfre
control
odn
carri
structur
sequenc
odn
except
cg
motif
invers
gc
odn
dissolv
endotoxinfre
water
recommend
supplier
administ
subcutan
dose
mgkg
bodi
weight
equal
distribut
four
locat
name
bilater
axillari
inguin
region
treatment
equal
volum
time
point
h
administr
treatment
h
h
h
h
h
h
h
cat
clinic
examin
weight
temperatur
note
addit
time
point
blood
sampl
oral
conjunctiv
rectal
swab
collect
cat
anim
sedat
sampl
collect
ml
medethomidin
dorben
dr
e
graeub
ag
bern
switzerland
ml
ketamin
narketan
vetoquinol
ag
ittigen
switzerland
antagon
shortli
thereaft
ml
atipamezol
alzan
dr
e
graeub
ag
peripher
blood
collect
jugular
vein
steril
condit
vacuett
tube
greiner
bioon
stgallen
switzerland
whole
blood
sampl
mix
messeng
rna
mrna
lysi
buffer
mrna
hs
kit
roch
diagnost
rotkreuz
switzerland
immedi
upon
blood
collect
hematolog
valu
hemoglobin
hgb
hematocrit
hct
mean
corpuscular
volum
mcv
mean
corpuscular
hemoglobin
mch
mean
corpuscular
hemoglobin
concentr
mchc
well
cell
count
total
red
blood
cell
total
white
blood
cell
neutrophil
lymphocyt
monocyt
eosinophil
basophil
separ
measur
sysmex
xt
sysmex
norderstedt
germani
collect
time
point
previous
describ
felin
speci
weissenbach
et
al
plasma
obtain
centrifug
whole
blood
sampl
min
g
cotton
swab
similar
qtip
rub
repeatedli
conjunctiv
oral
gingiva
rectal
mucosa
care
avoid
contamin
tissu
place
ml
collect
tube
cotton
tip
face
downward
process
steril
condit
follow
protocol
develop
group
gomeskel
et
al
briefli
swab
soak
phosphat
buffer
salin
pb
gibco
invitrogen
basel
switzerland
incub
c
min
sampl
centrifug
g
one
minut
swab
invers
within
tube
sampl
centrifug
g
one
minut
swab
discard
sampl
mix
mrna
lysi
buffer
mrna
hs
kit
roch
diagnost
recommend
manufactur
sampl
store
c
analysi
adher
feli
catu
whole
fetu
cell
atcc
maintain
emem
atcc
supplement
heatinactiv
fetal
calf
serum
bioconcept
allschwil
switzerland
uml
penicillin
mgml
streptomycin
gibco
invitrogen
preliminari
experi
reveal
edta
ad
plasma
collect
cat
toxic
cell
format
calciumedta
complex
addit
cacl
ratio
mole
plasma
complet
abrog
toxic
data
shown
viabil
cell
measur
h
incub
cacl
supplement
plasma
blood
collect
time
point
cat
format
use
trypan
blue
exclus
test
describ
previou
studi
roberttissot
et
al
whole
blood
mucos
cell
swab
process
describ
section
cell
grown
confluenc
plate
incub
h
cacl
supplement
plasma
see
section
collect
time
point
cat
lyse
mrna
lysi
buffer
mrna
hs
kit
roch
diagnost
mrna
extract
sampl
magna
pure
lc
instrument
roch
diagnost
protocol
provid
manufactur
complementari
dna
cdna
synthes
sampl
high
capac
cdna
revers
transcript
kit
appli
biosystem
rotkreuz
switzerland
realtim
quantit
pcr
qpcr
reaction
carri
l
cdna
total
volum
l
per
reaction
use
taqman
fast
univers
pcr
master
mix
appli
biosystem
amplif
target
sequenc
achiev
rotorgen
real
time
analyz
qiagen
ag
hombrechtikon
switzerland
run
condit
includ
initi
denatur
c
follow
amplif
cycl
consist
c
c
express
felin
housekeep
gene
gusb
tryptophan
activ
protein
zeta
polypeptid
ywhaz
microglobulin
well
felin
mx
gene
analyz
assay
previous
valid
group
kessler
et
al
roberttissot
et
al
rel
mx
mrna
express
factor
repres
ratio
mx
mrna
level
sampl
individu
time
point
compar
sampl
time
point
h
individu
cat
calcul
normal
two
select
housekeep
gene
genorm
softwar
version
vandesompel
et
al
materi
avail
certain
swab
analysi
limit
gener
result
depict
graph
ct
valu
involv
calcul
case
oral
swab
cat
collect
refer
time
point
h
mx
express
oral
mucos
cell
cat
could
unfortun
shown
miss
data
due
high
ct
valu
shown
respect
graph
addit
control
cat
sedat
h
post
treatment
inject
fulli
recov
previou
sedat
therefor
result
avail
anim
time
point
h
cell
grown
confluenc
format
treat
cacl
supplement
plasma
see
section
blood
collect
time
point
cat
incub
period
h
cell
inocul
five
time
tissu
cultur
infecti
dose
tcid
fcv
strain
stock
viru
kindli
provid
veterinaria
ag
zurich
switzerland
viru
previous
titrat
cell
dilut
induc
cytopath
effect
cpe
h
select
inhibit
experi
plaqu
assay
carri
h
inocul
cell
accord
protocol
alreadi
describ
vogel
et
al
valid
group
similar
experi
felin
cell
roberttissot
et
al
briefli
plasma
discard
well
nonviabl
cell
remov
consecut
wash
step
hank
balanc
salt
solut
hbss
gibco
invitrogen
ad
well
plate
place
orbit
shaker
remain
cell
fix
formalin
solut
stain
crystal
violet
spectrophotometr
measur
methanol
ad
dri
well
absorb
read
nm
spectramax
plu
microtit
plate
reader
molecular
devic
bucher
biotec
ag
basel
switzerland
viral
inhibit
factor
calcul
follow
formula
mean
optic
densiti
od
valu
duplic
well
treat
plasma
time
point
xhmean
od
valu
treat
plasma
time
point
h
untreat
cell
well
plate
inocul
fcv
serv
posit
control
untreat
noninocul
cell
well
plate
serv
neg
control
cell
posit
control
neg
control
well
optic
indic
cpe
cpe
respect
plaqu
assay
conduct
spearman
correl
analysi
level
mx
mrna
measur
blood
four
cat
experiment
time
point
fcv
inhibit
factor
induc
cell
incub
plasma
obtain
cat
time
point
perform
graphpad
prism
window
version
graphpad
softwar
san
diego
california
usa
treat
two
cat
odn
cat
receiv
control
treatment
odn
endotoxinfre
water
respect
four
cat
involv
experi
examin
clinic
sampl
collect
time
point
observ
behavior
chang
sever
occas
daili
gener
treatment
well
toler
anim
except
first
day
sever
sedat
take
place
behavior
cat
could
object
assess
cat
ate
play
normal
throughout
experi
addit
weight
loss
record
bodi
temperatur
cat
slightli
rose
maximum
c
within
first
h
experi
return
basal
level
h
post
inject
fig
howev
whether
increas
attribut
treatment
odn
question
bodi
temperatur
control
cat
also
increas
parallel
manner
sever
sedat
short
interv
first
day
experi
certainli
play
import
role
find
cours
experi
alter
observ
hematolog
paramet
test
except
decreas
hematocrit
measur
cat
time
point
h
h
data
shown
like
result
repeat
blood
collect
short
interv
aim
measur
potenti
odn
strengthen
innat
defens
mechan
system
vivo
mx
transcript
measur
time
blood
mrna
level
gene
increas
blood
odn
cat
alreadi
h
inject
molecul
fig
transcript
mx
continu
steadi
increas
first
h
experi
decreas
progress
reach
basal
level
h
h
post
inject
fig
peak
mx
express
measur
time
point
h
reach
basal
level
measur
prior
treatment
cat
respect
fig
next
order
evalu
extent
kinet
measur
antivir
respons
potenti
viral
entri
site
mx
transcript
analyz
cell
peripher
tissu
name
conjunctiv
oral
rectal
mucosa
mx
express
kinet
mucos
cell
odn
cat
follow
similar
pattern
observ
blood
anim
fig
although
substanti
increas
mx
transcript
observ
h
post
inject
mucos
tissu
test
express
gene
maxim
induc
within
h
return
slightli
basal
valu
within
h
conjunctiv
oral
rectal
mucos
cell
fig
conjunctiv
cell
present
highest
sensit
biolog
effect
odn
display
increas
mx
express
cat
time
point
h
fig
maxim
measur
mx
transcript
oral
rectal
cell
cat
respect
note
express
mx
could
analyz
oral
mucosa
cat
due
restrict
amount
materi
could
collect
swab
see
section
fig
stark
contrast
cat
mx
mrna
level
control
cat
remain
larg
unalt
throughout
experi
blood
mucos
tissu
fig
order
confirm
plasma
treat
cat
could
induc
antivir
state
target
cell
mx
mrna
express
level
compar
cell
incub
h
plasma
collect
variou
time
point
post
treatment
cell
ident
treat
plasma
collect
inject
time
point
h
rel
mx
mrna
level
measur
target
cell
incub
plasma
differ
experiment
time
point
trend
similar
manner
blood
mucos
cell
plasma
sampl
odn
cat
collect
h
h
post
inject
induc
increas
amount
mx
mrna
express
cell
peak
induct
approxim
cat
measur
time
point
h
fig
plasma
time
point
h
h
induc
progress
decreas
amount
mx
mrna
cultur
cell
return
basal
level
h
post
inject
congruenc
mx
mrna
level
measur
blood
plasma
induc
slightli
higher
mx
mrna
cell
time
point
plasma
cat
plasma
collect
control
cat
substanti
alter
mx
mrna
express
target
cell
final
step
abil
plasma
obtain
treat
cat
differ
time
point
inject
promot
resist
target
cell
viral
infect
evalu
end
cell
incub
h
plasma
time
point
cat
inocul
fcv
viral
replic
measur
addit
h
plasma
odn
cat
obtain
h
inject
could
reduc
infect
cell
cultur
fig
peak
viral
resist
factor
could
measur
treatment
cell
plasma
cat
obtain
blood
collect
time
point
h
wherebi
plasma
cat
display
stronger
effect
cat
plasma
collect
time
point
control
cat
fail
inhibit
viral
replic
cell
importantli
strong
correl
observ
measur
blood
mx
mrna
level
viral
inhibit
induc
vitro
plasma
collect
individu
cat
distinct
experiment
time
point
fig
present
studi
report
induct
innat
antivir
respons
vivo
domest
cat
refer
previou
vitro
result
roberttissot
et
al
util
odn
class
cpg
odn
singl
subcutan
inject
molecul
suffici
induc
system
biolog
effect
cat
accompani
signific
side
effect
antivir
defens
mechan
enhanc
approxim
day
administr
molecul
blood
peripher
mucos
cell
moreov
plasma
collect
odn
cat
day
post
inject
could
increas
express
antivir
effector
marker
gene
target
felin
cell
line
vitro
confer
cell
partial
resist
inocul
fcv
cpga
gain
much
less
popular
cpgb
clinic
applic
like
due
difficulti
synthesi
reduc
resist
endonucleas
among
studi
address
prophylact
potenti
cpg
odn
standalon
agent
one
util
class
molecul
mous
model
foot
mouth
diseas
viru
kamstrup
et
al
howev
sever
reason
applic
cpga
known
potent
induct
type
ifn
appear
particularli
interest
domest
cat
first
felin
virus
acquir
challeng
propag
strategi
throughout
evolut
surviv
domest
cat
time
suggest
select
potent
antivir
mechan
speci
along
line
almost
subtyp
felin
type
ifn
identifi
nagai
et
al
nakamura
et
al
wonderl
et
al
yang
et
al
antivir
properti
character
baldwin
et
al
taira
et
al
yang
et
al
persist
larg
number
function
ifn
gene
cat
reveal
evolutionari
import
defens
system
even
though
individu
role
gene
remain
uncov
second
recent
shown
odn
typic
class
molecul
could
stimul
express
variou
type
ifn
subtyp
gene
roberttissot
et
al
final
commerci
avail
recombin
ifn
subtyp
display
therapeut
benefit
context
variou
felin
viral
infect
collado
et
al
de
mari
et
al
haid
et
al
ishiwata
et
al
martin
et
al
minagawa
et
al
ohe
et
al
mx
mrna
express
use
studi
marker
induct
antivir
state
transcript
ifnstimul
gene
isg
directli
regul
signal
downstream
type
ifn
receptor
biolog
activ
type
ifn
reflect
express
mx
haller
koch
antivir
gene
express
cell
possess
receptor
distribut
ubiquit
nucleat
cell
mx
util
indic
type
ifn
activ
almost
cell
type
altogeth
properti
led
util
mx
marker
upregul
type
ifn
variou
anim
speci
francoi
et
al
jung
chae
mullerdobl
et
al
confirm
direct
correl
mx
type
ifn
express
felin
cell
previou
vitro
studi
roberttissot
et
al
furthermor
although
antivir
activ
mx
known
direct
negativestrand
rna
virus
eg
orthomyxovirus
haller
koch
found
strong
correl
induc
mx
express
felin
target
cell
resist
cell
varieti
felin
virus
roberttissot
et
al
specif
select
isg
like
play
import
role
antivir
mechan
confer
resist
individu
felin
virus
howev
mx
express
appear
reliabl
reflect
presenc
felin
cell
final
link
studi
mx
mrna
level
blood
vivo
potenti
plasma
confer
resist
fcv
target
cell
vitro
confirm
relev
mx
marker
strength
antivir
defens
mechan
cat
aim
induc
system
antivir
state
cat
could
temporarili
increas
resist
broad
rang
viral
infect
result
studi
promis
singl
inject
odn
induc
clinic
side
effect
could
initi
antivir
defens
mechan
detect
blood
conjunctiv
well
oral
rectal
mucos
cell
although
bodi
temperatur
odn
cat
slightli
rose
within
first
h
experi
stronger
temperatur
increas
observ
control
cat
time
alter
bodi
temperatur
anim
initi
phase
experi
thu
like
attribut
stress
induc
consecut
sedat
short
interv
sampl
collect
advers
reaction
odn
addit
safeti
administr
molecul
exhibit
system
antivir
effect
common
felin
virus
includ
fcv
fhv
fpv
felv
enter
host
oronas
conjunctiv
rout
radford
et
al
thiri
et
al
truyen
et
al
crucial
tissu
peripher
site
also
upregul
antivir
defens
mechan
fcov
turn
enter
host
oronas
mainli
replic
intestin
cell
although
could
measur
mx
express
rectal
cell
due
restrict
access
digest
tract
live
cat
cell
surfac
earlier
segment
gut
presum
increas
mx
express
similar
pattern
observ
mucos
cell
studi
could
addit
show
plasma
odn
cat
could
induc
antivir
state
cultur
felin
cell
also
increas
resist
cell
fcv
field
environment
factor
may
weaken
pathogen
infecti
viru
may
dissemin
sporad
variabl
dose
infecti
pressur
like
lower
cell
cultur
well
confer
host
temporari
immun
advantag
may
thu
suffic
enhanc
protect
infect
although
protein
level
antivir
molecul
could
detect
studi
due
lack
antibodi
suffici
specif
felin
speci
biolog
activ
could
assess
inde
plasma
collect
day
post
odn
inject
cat
could
inhibit
viral
replic
cell
vitro
suggest
induct
system
antivir
mechan
cat
persist
sever
day
admittedli
effect
cat
gener
lower
cat
variabl
respons
stimul
innat
immun
respons
howev
expect
outbr
speci
note
experi
vitro
stimul
felin
immun
cell
odn
indic
although
certain
individu
gener
respond
better
other
variabl
among
adult
cat
limit
studi
plan
refin
prophylact
antivir
treatment
domest
cat
structur
dosag
administr
strategi
odn
revis
combin
variou
adjuv
may
consid
prolong
antivir
effect
larger
number
cat
includ
futur
experi
order
precis
assess
variabl
antivir
effect
vivo
final
optim
condit
efficaci
prophylact
stimul
innat
antivir
defens
odn
test
shelter
set
teflon
domest
cat
may
around
corner
author
declar
conflict
interest
